Ironwood Pharmaceuticals to Highlight Clinical Data for IW-3718 in Persistent Gastroesophageal Reflux Disease (GERD) at Digestive Disease Week® 2018
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Highlight-Clinical-Data-for-IW-3718-in-Persistent-Gastroesophageal-Reflux-Disease-GERD-at-Digestive-Disease-Week-2018/default.aspx
Ironwood Pharmaceuticals to Highlight Clinical Data for IW-3718 in Persistent Gastroesophageal Reflux Disease (GERD) at Digestive Disease Week® 2018
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Highlight-Clinical-Data-for-IW-3718-in-Persistent-Gastroesophageal-Reflux-Disease-GERD-at-Digestive-Disease-Week-2018/default.aspx
Ironwood Pharmaceuticals Sends Letter to Shareholders Highlighting Director Nominees
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Sends-Letter-to-Shareholders-Highlighting-Director-Nominees/default.aspx
Ironwood Pharmaceuticals Sends Letter to Shareholders Highlighting Director Nominees
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Sends-Letter-to-Shareholders-Highlighting-Director-Nominees/default.aspx
Ironwood Pharmaceuticals Files Investor Presentation Highlighting Actions Taken Designed to Unlock Shareholder Value
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Files-Investor-Presentation-Highlighting-Actions-Taken-Designed-to-Unlock-Shareholder-Value/default.aspx
Ironwood Pharmaceuticals Files Investor Presentation Highlighting Actions Taken Designed to Unlock Shareholder Value
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Files-Investor-Presentation-Highlighting-Actions-Taken-Designed-to-Unlock-Shareholder-Value/default.aspx
Ironwood and Allergan Announce Settlement with Aurobindo Pharma Resolving LINZESS® (linaclotide) Patent Litigation
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-and-Allergan-Announce-Settlement-with-Aurobindo-Pharma-Resolving-LINZESS-linaclotide-Patent-Litigation/default.aspx
Ironwood and Allergan Announce Settlement with Aurobindo Pharma Resolving LINZESS® (linaclotide) Patent Litigation
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-and-Allergan-Announce-Settlement-with-Aurobindo-Pharma-Resolving-LINZESS-linaclotide-Patent-Litigation/default.aspx
Ironwood Pharmaceuticals Files Definitive Proxy Materials and Mails Letter to Shareholders
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Files-Definitive-Proxy-Materials-and-Mails-Letter-to-Shareholders/default.aspx
Ironwood Pharmaceuticals Files Definitive Proxy Materials and Mails Letter to Shareholders
https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Files-Definitive-Proxy-Materials-and-Mails-Letter-to-Shareholders/default.aspx